Hospital Povisa S.A.

Vigo 8 trials 1 recruiting

8 Registered trials

1 Currently recruiting

Organisation

Hospital Povisa S.A.

Location

Vigo, Spain

Identifier

ORG-100047448

Address

Rua Salamanca 5, 36211, Spain

Departments

72401 Medicina Interna
Allergy
Anestesiología y Reanimación
Internal Medicine Service
Neurology
Oncology
Pneumology

Clinical trials at this site (8)

Search interface

A study to compare pharmacokinetics, efficacy, safety, and immunogenicity of MB12 (proposed pembrolizumab biosimilar) to Keytruda® in non-sm… Recruiting

2024-515853-48-00 advanced/metastatic non-squamous non-small cell lung ca 5 2025-09-05
A Phase 3 Trial Comparing Whether BEM/RZR is Similar to SOF/VEL in Patients with Hepatitis C Virus Infection Ended

2025-521096-31-00 Chronic Hepatitis C Virus (HCV) Infection 5 2025-10-02
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Fluad and Fluad … Ended

2022-503004-24-00 Influenza virus 5 2023-10-20
A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) Ended

2023-503693-20-01 Severe eosinophilic asthma 5 2024-04-10
A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients with Early Alzheimer’s Disease with Biomarkers of Inflammation Ended

2023-505396-71-00 Early Alzheimer’s Disease with Biomarkers of Inflammati 4 2024-03-01
Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line o… Ended

2023-508860-31-00 Stage IV colon or rectal adenocarcinoma (mCRC). 5 2023-02-28
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 Ended

2024-519691-10-00 Septic Shock 6 2022-05-27
Clinical trial to assess the efficacy and safety of a vaccine for dust mite allergy Ended

2024-514090-21-00 Aetiological treatment of moderate - severe intermitten 5 2020-08-05